These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 11746970)
1. Genotypic and phenotypic progression in endometrial tumorigenesis: determining when defects in DNA mismatch repair and KRAS2 occur. Cohn DE; Mutch DG; Herzog TJ; Rader JS; Dintzis SM; Gersell DJ; Todd CR; Goodfellow PJ Genes Chromosomes Cancer; 2001 Dec; 32(4):295-301. PubMed ID: 11746970 [TBL] [Abstract][Full Text] [Related]
2. RAS/RAF mutation and defective DNA mismatch repair in endometrial cancers. Mutch DG; Powell MA; Mallon MA; Goodfellow PJ Am J Obstet Gynecol; 2004 Apr; 190(4):935-42. PubMed ID: 15118616 [TBL] [Abstract][Full Text] [Related]
3. Differences in patterns of TP53 and KRAS2 mutations in a large series of endometrial carcinomas with or without microsatellite instability. Swisher EM; Peiffer-Schneider S; Mutch DG; Herzog TJ; Rader JS; Elbendary A; Goodfellow PJ Cancer; 1999 Jan; 85(1):119-26. PubMed ID: 9921983 [TBL] [Abstract][Full Text] [Related]
4. Microsatellite instability, MLH1 promoter methylation, and loss of mismatch repair in endometrial cancer and concomitant atypical hyperplasia. Horowitz N; Pinto K; Mutch DG; Herzog TJ; Rader JS; Gibb R; Bocker-Edmonston T; Goodfellow PJ Gynecol Oncol; 2002 Jul; 86(1):62-8. PubMed ID: 12079302 [TBL] [Abstract][Full Text] [Related]
5. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients. de Leeuw WJ; Dierssen J; Vasen HF; Wijnen JT; Kenter GG; Meijers-Heijboer H; Brocker-Vriends A; Stormorken A; Moller P; Menko F; Cornelisse CJ; Morreau H J Pathol; 2000 Nov; 192(3):328-35. PubMed ID: 11054716 [TBL] [Abstract][Full Text] [Related]
6. Strong correlation between molecular changes in endometrial carcinomas and concomitant hyperplasia. Zauber P; Denehy TR; Taylor RR; Ongcapin EH; Marotta S; Sabbath-Solitare M Int J Gynecol Cancer; 2015 Jun; 25(5):863-8. PubMed ID: 25768080 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers. Goodfellow PJ; Buttin BM; Herzog TJ; Rader JS; Gibb RK; Swisher E; Look K; Walls KC; Fan MY; Mutch DG Proc Natl Acad Sci U S A; 2003 May; 100(10):5908-13. PubMed ID: 12732731 [TBL] [Abstract][Full Text] [Related]
8. Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability. Vassileva V; Millar A; Briollais L; Chapman W; Bapat B Cancer Res; 2002 Jul; 62(14):4095-9. PubMed ID: 12124347 [TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis. Peterson LM; Kipp BR; Halling KC; Kerr SE; Smith DI; Distad TJ; Clayton AC; Medeiros F Int J Gynecol Pathol; 2012 May; 31(3):195-205. PubMed ID: 22498935 [TBL] [Abstract][Full Text] [Related]
10. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis. Koul A; Willén R; Bendahl PO; Nilbert M; Borg A Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762 [TBL] [Abstract][Full Text] [Related]
11. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis. Berends MJ; Wu Y; Sijmons RH; van der Sluis T; Ek WB; Ligtenberg MJ; Arts NJ; ten Hoor KA; Kleibeuker JH; de Vries EG; Mourits MJ; Hollema H; Buys CH; Hofstra RM; van der Zee AG J Clin Oncol; 2003 Dec; 21(23):4364-70. PubMed ID: 14645426 [TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability and expression of mismatch repair genes in sporadic endometrial cancer coexisting with colorectal or breast cancer. Takano K; Ichikawa Y; Ueno E; Ohwada M; Suzuki M; Tsunoda H; Miwa M; Uchida K; Yoshikawa H Oncol Rep; 2005 Jan; 13(1):11-6. PubMed ID: 15583795 [TBL] [Abstract][Full Text] [Related]
14. Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma. Dobrzycka B; Terlikowski SJ; Mazurek A; Kowalczuk O; Niklińska W; Chyczewski L; Kulikowski M Folia Histochem Cytobiol; 2009; 47(1):65-8. PubMed ID: 19419940 [TBL] [Abstract][Full Text] [Related]
15. Target gene mutation profile differs between gastrointestinal and endometrial tumors with mismatch repair deficiency. Duval A; Reperant M; Compoint A; Seruca R; Ranzani GN; Iacopetta B; Hamelin R Cancer Res; 2002 Mar; 62(6):1609-12. PubMed ID: 11912129 [TBL] [Abstract][Full Text] [Related]
16. Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study. Stefansson I; Akslen LA; MacDonald N; Ryan A; Das S; Jacobs IJ; Salvesen HB Clin Cancer Res; 2002 Jan; 8(1):138-43. PubMed ID: 11801550 [TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma. Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545 [TBL] [Abstract][Full Text] [Related]
18. Birt-Hogg-Dubé gene mutations in human endometrial carcinomas with microsatellite instability. Fujii H; Jiang W; Matsumoto T; Miyai K; Sashara K; Ohtsuji N; Hino O J Pathol; 2006 Jul; 209(3):328-35. PubMed ID: 16691634 [TBL] [Abstract][Full Text] [Related]